Art
J-GLOBAL ID:201802250396837641   Reference number:18A1790879

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study

ペルツズマブ,トラスツズマブおよび化学療法の前治療を受けたHER2陽性局所進行/転移性乳癌患者におけるペルツズマブ再投与の無作為化,非盲検,第III相試験:日本乳癌研究グループ-M05 PRECIOUS試験
Author (19):
Material:
Volume: 48  Issue:Page: 855-859 (WEB ONLY)  Publication year: Sep. 2018 
JST Material Number: U1085A  ISSN: 1465-3621  Document type: Article
Article type: 解説  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1790879&from=J-GLOBAL&jstjournalNo=U1085A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for tumors 

Return to Previous Page